Outdoor Emergency Room sign
·
4 Min Read

Embracing harm reduction in the emergency department

Learn about work by Phoenix emergency physicians to get naloxone directly into the hands of patients at risk of overdose.

Behavioral Health
·
3 Min Read

Dec. 3, 2021: State Advocacy Update

AMA urges nation’s naloxone manufactures to make product OTC and more in the latest State Advocacy Update.

Advocacy Update
·
1 Min Read

AMA statement on FDA decision on naloxone nasal

AMA commends FDA’s approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.

Press Releases
·
2 Min Read

AMA applauds FDA for requiring naloxone information on opioid labels

The new labeling can serve as a starting point for discussion between patients and physicians about risks and benefits associated with opioids.

Press Releases
·
5 Min Read

July 10, 2020: State Advocacy Update

AMA urges all states to follow Michigan effort to increase access to naloxone and more in the latest State Advocacy Update.

Advocacy Update
·
5 Min Read

Feb. 28, 2020: State Advocacy Update

Warning on naloxone in CO, prior authorization in ME and more in AMA's latest state advocacy efforts.

Advocacy Update
Naloxone injector.
·
2 Min Read

Lifesaving naloxone should be available almost everywhere

Publicly available naloxone rescue boxes could allow bystanders to save the lives of people experiencing opioid overdoses.

Behavioral Health
·
3 Min Read

AMA strengthens its policies promoting naloxone access and education

Physicians and medical students acted today to strengthen existing AMA policy promoting increased access to naloxone, the opioid overdose-reversing drug.

Press Releases
Elizabeth Salisbury-Afshar, MD, MPH
·
3 Min Read

Anyone can save a life with naloxone: What patients should know

The signs of an overdose, how to administer naloxone, and the toll of stigma covered by experts in a presentation at AMA’s Chicago headquarters.

Behavioral Health